The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

Oncogenic fusions in invasive mucinous LDAC. A, schematic

Rare molecular subtypes of lung cancer

Empire Genomics Interviews With Today's Leading Researchers

ROS1-dependent cancers - biology, diagnostics and therapeutics

2022肺癌靶标热点追击，ERRα/LTK/EMSY初露锋芒-源井生物- 哔哩哔哩

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung

Combinatorial tumor suppressor inactivation efficiently initiates

肺癌靶点研究渐露锋芒，源井生物基因编辑细胞助力肿瘤研究_源井生物

Department of Thoracic Oncology National Cancer Center Hospital East

Nature：非小细胞肺癌新靶点CLIP1-LTK被发现，劳拉替尼效果不错@MedSci

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect

Comparison of ALK and LTK structure and sequence. (A) Schematic of ALK

Frequency of co-occurring aberrations with KRAS-mutant non-small

Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver